Health Update Bahamas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Update Bahamas.

Press releases published on November 5, 2026

17 hours ago

RenovoRx Reports Record Third Quarter 2026 Revenue Exceeding $1 Million

Indeterminate GlobeNewswire

17 hours ago

Equillium to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

17 hours ago

Profound Medical Reports Strong Third Quarter 2026 Results; Expands U.S. Distribution and Positions Leadership for Next Phase of Growth

Indeterminate GlobeNewswire

17 hours ago

Attovia Therapeutics Announces Positive Topline 12-Week Results from Phase 1b Study of ATTO-1310 in Patients with Chronic Pruritus and High-Itch Atopic Dermatitis

Indeterminate GlobeNewswire

17 hours ago

Aprea Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

17 hours ago

Health Catalyst Reports Third Quarter 2026 Results

Indeterminate GlobeNewswire

17 hours ago

Omada Health Reports Third Quarter 2026 Results

Indeterminate GlobeNewswire

17 hours ago

Kyverna Therapeutics to Present at the Jefferies London Healthcare Conference

Indeterminate GlobeNewswire

17 hours ago

Allogene Therapeutics Reports Third Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire

17 hours ago

Globus Medical Reports Third Quarter 2026 Results and Announces a $500 Million Increase to the Share Repurchase Program

Indeterminate GlobeNewswire

17 hours ago

Rakovina Therapeutics Announces Shares for Debt Transaction

Indeterminate GlobeNewswire

17 hours ago

vTv Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

17 hours ago

Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

17 hours ago

Voyager Reports Third Quarter 2026 Financial and Operating Results

Indeterminate GlobeNewswire

17 hours ago

aTyr Pharma Announces Third Quarter 2026 Results and Provides Corporate Update

Indeterminate GlobeNewswire

17 hours ago

Celldex Reports Third Quarter Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

17 hours ago

Biodesix Announces Third Quarter 2026 Results and Highlights

Indeterminate GlobeNewswire

17 hours ago

Eton Pharmaceuticals Announces Preliminary ET-700 Pilot Study Results Evaluating Copper Absorption Inhibition and Gastrointestinal Tolerability

Indeterminate GlobeNewswire

17 hours ago

Ascendis to Report Third Quarter 2026 Financial Results and Provide Business Update on November 12, 2026

Indeterminate GlobeNewswire

17 hours ago

Dentsply Sirona Reports Third Quarter 2026 Results

Indeterminate GlobeNewswire